Think Global, Act Local
Authors: Tanchuco Joven Jeremius Q. 
Published: September 2022

In the Philippines, many people would think that items made in other countries have better quality and are more desirable.More recently, with numerous goods coming from nearby countries also having built their reputation for similar or even betterquality – for example, those coming from Japan, Taiwan and more lately, China – goods from these countries are now alsopopular. But it remains unusual that we would generally prefer local brands, i.e., those made in the Philippines.When it comes to using scientific evidence as basis for local medical practice, it should be argued that high quality localdata is superior and should be used. After all, it is derived from our countrymen who may have a different disease biology and/or natural history, sociocultural determinants, as well as clinical practices. It is unfortunate, however, that such local data arenot always available. Even if it exists, it is also not easily accessible.
In this, and other issues of Acta Medica Philippina, we see some of the efforts being made by our colleagues to look intothis local experience. They offer varied insights into how global diseases are manifested locally: are there differences that weshould be aware of?
As far back as 2006, the Philippine Council for Health Research and Development (PCHRD) has already facilitatedthe creation of a National Unified Health Research Agenda (NUHRA) which is reviewed every five years to identifyresearch priorities in the Philippines.1 In its latest iteration, the 2017-2022 NUHRA prioritizes among others, the holisticapproach to health and wellness that aims to produce evidence geared towards the application and recognition of traditional,sociocultural, and alternative approaches to health.2 The study by Sanico and Medina in this issue highlights this objective.It looked into the potential health benefits and risks of an indigenous fermented rice wine called tapuy. Utilizing a modernbiotechnology technique called metagenomic sequencing, the authors found significant presence of probiotic bacteria thatcan be explored for health applications. However, they also detected the presence of harmful bacteria which may indicate theneed for possible standardization of the fermentation practices.
The Acquired Immunodeficiency Syndrome (AIDS) has long plagued the global landscape ever since it was first describedin 1981.3 Because cases have not been described previously, AIDS with its increasing numbers, was soon labeled as anepidemic.4,5 In the Philippines, the HIV/AIDS epidemic has been a fairly more recent one.6-9 Sadly, our country is nowidentified as one with the fastest growing HIV epidemic in the Western Pacific.10 Identifying perceptions of the generalcommunity, especially the high risk populations, can go a long way in curtailing the rising numbers.11 The article by Jamesand colleagues looked further into this by evaluating the knowledge, attitudes and practices on prevention and transmission ofHIV/AIDS among college students in Pampanga, Philippines. The participants were found to have a low knowledge of HIV/AIDS, but had a good attitude toward HIV positive individuals. The authors recommended that education on HIV/AIDScould help control the local epidemic.
The study by Rogelio and Santiago looked into screening for retinopathy in patients with gestational diabetes mellitus(GDM). Their data did not support screening to be done in this population. A study had previously reported that GDM has aprevalence of 14% in the Philippines making GDM a disease that is worth addressing.12 On a related note, several internationalguidelines define how GDM can be diagnosed.13 The Philippine Obstetrics and Gynecology Society advocates for a one-stepapproach (a single OGTT using a 75-g anhydrous glucose load with fasting blood sugar ≥92 mg/dL, and a 2-hour level of<126 mg/dL). The one-step approach may be more convenient for patients as it also needs a single visit. A recent report fromAustralia, which also follows a one-step screening process, showed at least a 25% overdiagnosis and its consequent need forfurther testing and the patient anxiety that goes with it.14 An earlier US study also showed 50% more women diagnosed withGDM using the one-step approach compared to a two-step one.15 To be fair, the US study, similar to another one done alsoin Australia, showed no significant differences in the pregnancy outcomes between the two approaches.16 Although a localstudy identified numerical differences in pregnancy outcomes (e.g., risk for primary caesarean section, large for gestational ageinfants, etc.) comparing the two criteria, these were not found to be statistically significant.13 Perhaps there is a need to lookinto this matter again using larger cohorts. As the Philippines gears up for Universal Healthcare, the outcomes of screeningfor GDM can become even more important.
The article by Arcilla, et al., on validation of foreign instruments to assess disease and treatment outcomes representsanother area where local data is needed.17 Such validation seeks to investigate whether an instrument developed elsewhere willlikewise yield accurate – and comparable – data for which it was intended. The BREAST-Q is a patient-reported outcomeinstrument designed to evaluate outcomes among women undergoing different types of breast surgery.18 The authors foundhigh internal consistency, test-retest reliability, and acceptability. But there was only low to moderate construct validity inthe Filipino cohort. Among other findings, the authors report respondents having difficulty in understanding some languagetranslations, and even negative reactions to some of the questions. The authors recommend further studies with a largernumber of respondents including those who have undergone nipple reconstruction. The initial results also note that it may bebetter to interpret the “sexual well-being” subscale separately because of the influence that culture may play.
The study of Manalili, et al. looked into hemoperfusion as an intervention for COVID-19. The authors report a highmortality and a long length of hospital stay. To put this into perspective, the period of study was from April to September 2020,early in the pandemic period when little is relatively known about the disease. Since then, we know more about COVID-19,with vaccination and anti-virals being available that could alter the disease severity. As of December 2021, local experts donot recommend the use of hemoperfusion among patients diagnosed with COVID-19 mostly because of low certainty ofevidence.19 The option to use it in COVID-19 patients with clinical deterioration despite standard medical therapy includingtocilizumab is however still suggested. The study published here would have been more interesting if there was a comparisonof the outcomes with a similar group who did not undergo hemoperfusion. But it certainly illustrates how generating localdata and local experience goes a long way in examining relevant medical practice/s in our Philippine setting.
Case reports help to enhance clinical knowledge by describing the profile and management of patients who have anuncommon or rare disease or may have presented atypically.20-22 We have the opportunity in this issue to share four of theserare cases. The report submitted by Terencio, et al. on the combination of COVID-19 and Guillain-Barre syndrome (GBS)allows us better understanding of COVID-19 and its neurologic complications. As we continue to gain more importantinformation on COVID-19, describing the possibility of GBS as a possible consequence can help clinicians anticipate additionaltreatments as in this case. The same is true for the report submitted by Ablaza and Salonga-Quimpo on abdominal dyskinesia(with its more colorful description as “belly dancer dyskinesia”).
Then we have the case of SOLAMEN syndrome, reported by Maceda and colleagues. This case is more dramatic in thatit presents with disfigurement of the patient. Its management is more nuanced as it requires a multidisciplinary approachto address all the affected body parts.23,24 Unfortunately, it also has a strong genetic component as well as predilection tomalignancy which would require longer-term care. Another genetic disease, X-linked dystonia parkinsonism, is likewisereported in this issue in the article by Jamora and others. It is a rare movement disorder that is highly prevalent in Panay Islandin the Philippines.25-28 All cases described so far have been linked to Filipino ancestry, suggesting a single genetic founder andgenetic homogeneity. Although extremely rare globally, the prevalence of XDP in the Philippines is 0.31 per 100,000; and inPanay Island, 5.74 per 100,000. Ninety-five percent of affected individuals are males; the average age is 44 years (20–70 years);and the average age at onset is 39 years (12–64 years).27 Cases in patients of Filipino descent have been described in othercountries.29 The report published here is of particular interest as it is the first time the procedure called Unilateral TranscranialMagnetic Resonance-guided Focused Ultrasound Pallidothalamic Tractotomy has been tried for this condition; a conditionwhich leads to significant progressive disability but no definite treatment.27
All of these case reports may well be the first ones in the Philippines and we have it published here in Acta MedicaPhilippina.
I am certain there will be many more insightful studies done locally that will be published – and had been published – inthis journal. These are testament to the recognition that even as we are able to think following the highest global standards,we are also able to act (and do studies) locally in ways that are beneficial to our own Philippine community.
Joven Jeremius Q. Tanchuco, MD, MHA Department of Biochemistry and Molecular Biology College of Medicine, University of the Philippines Manila

REFERENCES1. Philippine National Health Research System. National Unified Health Research Agenda 2017-2022 [Internet]. [cited 2022 Sep 9]. Available from: https://www.healthresearch.ph/index.php/nuhra2. National Unified Health Research Agenda 2017-2022. Philippine National Health Research System [Internet]. [cited 2022 Sep 9].Available from: https://doh.gov.ph/sites/default/files/publications/NUHRA.pdf3. Schmid S. The Discovery of HIV-1. Nature Communications [Internet]. [cited 2022 Sep 9]. Available from: https://www.nature.com/articles/d42859-018-00003-x#:~:text=In%201983%2C%20Luc%20Montagnier’s%20team,AIDS)%2C%20such%20as%20lymphadenopathy.4. Curran JW, Jaffe HW, Centers for Disease Control and Prevention (CDC). AIDS: the early years and CDC’s response. MMWR Suppl.2011 Oct; 60(4):64-9.5. Sencer DJ. The AIDS Epidemic in the United States, 1981-early 1990s. Centers of Disease Control and Prevention [Internet]. [cited2022 Sep 12]. Available from: https://www.cdc.gov/museum/online/story-of-cdc/aids/index.html6. Restar A, Nguyen M, Nguyen K, Adia A, Nazareno J, Yoshioka E, et al. Trends and emerging directions in HIV risk and prevention researchin the Philippines: A systematic review of the literature. PLoS One. 2018 Dec;13(12):e0207663. doi: 10.1371/journal.pone.02076637. Adia AC, Bermudez ANC, Callahan MW, Hernandez LI, Imperial RH, Operario D. “An Evil Lurking Behind You”: Drivers, Experiences,and Consequences of HIV-Related Stigma Among Men Who Have Sex With Men With HIV in Manila, Philippines. AIDS Educ Prev.2018 Aug;30(4):322-334. doi: 10.1521/aeap.2018.30.4.3228. Mateo R Jr, Sarol JN Jr, Poblete R. HIV/AIDS in the Philippines. AIDS Educ Prev. 2004 Jun;16(3 Suppl A):43-52. doi: 10.1521/aeap.16.3.5.43.355199. Farr AC, Wilson DP. An HIV epidemic is ready to emerge in the Philippines. J Int AIDS Soc. 2010 Apr;13:16. doi: 10.1186/1758-2652-13-1610. Cousins S. The fastest growing HIV epidemic in the western Pacific. Lancet HIV. 2018 Aug;5(8):e412-e413. doi: 10.1016/S2352-3018(18)30182-611. de Lind van Wijngaarden JW, Ching AD, Settle E, van Griensven F, Cruz RC, Newman PA. “I am not promiscuous enough!”: Exploringthe low uptake of HIV testing by gay men and other men who have sex with men in Metro Manila, Philippines. PLoS One. 2018Jul;13(7):e0200256. doi: 10.1371/journal.pone.020025612. Litonjua AD, Waspadji S, Pheng CS, Phin KL, Deerochanowong C, Gomez MHS, et al. AFES Study Group on Diabetes in Pregnancy.Philipp J Intern Med. 1996 Mar-Apr; 34(2):67-68.13. Urbanozo H, Isip-Tan IT. 2014. Association of Gestational Diabetes Mellitus Diagnosed using the IADPSG and the POGS 75-gramOral Glucose Tolerance Test Cut-off Values with Adverse Perinatal Outcomes in the Philippine General Hospital. J ASEAN Fed EndocrSoc. 2014;29(2):157-162. doi: 10.15605/jafes.029.02.0914. Doust JA, Glasziou PP, dʼEmden MC. A large trial of screening for gestational diabetes mellitus in the United States highlights theneed to revisit the Australian diagnostic criteria. Med J Aust. 2022 Feb;216(3):113-115. doi: 10.5694/mja2.5138815. Hillier TA, Pedula KL, Ogasawara KK, Vesco KK, Oshiro CES, Lubarsky SL, et al. A Pragmatic, Randomized Clinical Trial ofGestational Diabetes Screening. N Engl J Med. 2021 Mar;384(10): 895-904. doi: 10.1056/NEJMoa202602816. Meloncelli NJL, Barnett AG, D’Emden M, De Jersey SJ. Effects of Changing Diagnostic Criteria for Gestational Diabetes Mellitus inQueensland, Australia. Obstet Gynecol. 2020 May;135(5):1215-1221. doi: 10.1097/AOG.000000000000379017. Elangovan N, Sundaravel E. Method of preparing a document for survey instrument validation by experts. MethodsX. 2021 Apr;8:101326. doi: 10.1016/j.mex.2021.10132618. BREAST-Q User’s Manual Version 2.0 May 2015. Copyright © 2012 Memorial Sloan Kettering Cancer Center [Internet]. [cited 2022Sep 12]. Available from: https://www.rcseng.ac.uk › breastq-usermanual-2015.19. Philippine COVID-19 Living Clinical Practice Guidelines. Institute of Clinical Epidemiology, National Institutes of Health, UP Manilaand the Philippine Society of Microbiology and Infectious Diseases [Internet]. [cited 2022 Sep 1]. Available from: https://www.psmid.org/hemoperfusion-evidence-summary-2/20. Ortega-Loubon C, Culquichicón C, Correa R. The Importance of Writing and Publishing Case Reports During Medical Training.Cureus. 2017 Dec;9(12):e1964. doi: 10.7759/cureus.196421. Case Reports. CARE Case Report Guidelines [Internet]. [cited 2022 Sep 12]. Available from: https://www.care-statement.org/case-reports22. Carey JC. The importance of case reports in advancing scientific knowledge of rare diseases. Adv Exp Med Biol. 2010; 686:77-86.doi: 10.1007/978-90-481-9485-8_523. Caux F, Plauchu H, Chibon F, Faivre L, Fain O, Vabres P, et al. Segmental overgrowth, lipomatosis, arteriovenous malformation andepidermal nevus (SOLAMEN) syndrome is related to mosaic PTEN nullizygosity. Eur J Hum Genet. 2007 Jul;15(7):767-73. doi: 10.1038/sj.ejhg.520182324. Gupta SK, Sushantika, Abdelmaksoud A. Isolated SOLAMEN Syndrome. Indian J Dermatol. 2021 Sep-Oct; 66(5):561-563. doi:10.4103/ijd.IJD_675_20.25. Domingo A, Westenberger A, Lee LV, Braenne I, Liu T, Vater I, et al. New insights into the genetics of X-linked dystonia-parkinsonism(XDP, DYT3). Eur J Hum Genet. 2015 Oct;23(10):1334-40. doi: 10.1038/ejhg.2014.29226. Lee LV, Munoz EL, Tan KT, Reyes MT. Sex linked recessive dystonia parkinsonism of Panay, Philippines (XDP). Mol Pathol. 2001Dec;54(6):362-368.27. Lee LV, Rivera C, Teleg RA, Dantes MB, Pasco PMD, Jamora RDG, et al. The unique phenomenology of sex-linked dystonia parkinsonism(XDP, DYT3, “Lubag”). Int J Neurosci. 2011;121 Suppl 1:3-11. doi: 10.3109/00207454.2010.52672828. Wilhelmsen KC, Weeks DE, Nygaard TG, Moskowitz CB, Rosales RL, dela Paz DC, et al. Genetic mapping of “Lubag” (X-linkeddystonia-parkinsonism) in Filipino kindred to the pericentromeric region of the X chromosome. Ann Neurol. 1991 Feb;29(2):124-31.doi: 10.1002/ana.41029020329. Rosales RL. X-linked dystonia parkinsonism: clinical phenotype, genetics and therapeutics. J Mov Disord. 2010 Oct;3(2):32–8. doi:10.14802/jmd.10009.